USANA to Report Q4 Earnings with Analysts Forecasting 5.8% Revenue Gain
USANA Health Sciences will release Q4 earnings tomorrow after market close, with analysts forecasting revenue of $226 million, up 5.8% year-over-year, and adjusted earnings per share of $0.41. In Q3 the company reported $213.7 million in revenue, a 6.7% increase, topping EBITDA projections but missing gross margin estimates.
1. Upcoming Q4 Earnings Release
USANA Health Sciences is set to announce its fourth-quarter financial results tomorrow after the market closes. Investors will be watching guidance and commentary on margins and regional performance to gauge momentum heading into 2026.
2. Analyst Expectations
Consensus estimates call for revenue of $226 million, representing a 5.8% year-over-year increase, and adjusted earnings per share of $0.41 for the quarter. Analysts have largely maintained their projections over the past month, reflecting steady confidence in the company’s product demand.
3. Q3 Performance Recap
In the previous quarter, USANA generated $213.7 million in revenue, up 6.7% year-over-year, and exceeded EBITDA forecasts despite falling short of gross margin estimates. The company’s mixed margin performance will be a key focus for stakeholders.
4. Peer Comparison and Market Sentiment
Peers in the personal care segment reported robust results—e.l.f. Beauty delivered 37.8% revenue growth while Estée Lauder saw a 5.6% increase—with average sector share prices rising 3.7% over the last month. In contrast, USANA’s stock has declined 4.9% over the same period, though its $39 average analyst price target suggests substantial upside potential.